We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+0.73%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$46.6B
AUM Growth
-$1.27B
(-2.6%)
Cap. Flow
-$2.28B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
19.53%
Holding
1,157
New
166
Increased
296
Reduced
323
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$208M |
| 2 |
Mastercard
MA
|
+$198M |
| 3 |
Kinder Morgan
KMI
|
+$174M |
| 4 |
Parker-Hannifin
PH
|
+$170M |
| 5 |
Check Point Software Technologies
CHKP
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$247M |
| 2 |
Pfizer
PFE
|
+$179M |
| 3 |
DuPont de Nemours
DD
|
+$149M |
| 4 |
Credicorp
BAP
|
+$138M |
| 5 |
McKesson
MCK
|
+$134M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.46% |
| 2 | Communication Services | 14.94% |
| 3 | Technology | 11.88% |
| 4 | Financials | 10.97% |
| 5 | Energy | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Bristol-Myers Squibb
BMY
$130B
| $260M | 0.56% |
5,081,954
-316,789
| -6% | -$15.8M |
|
52
Norwegian Cruise Line
NCLH
$9.64B
| $256M | 0.55% |
7,097,978
+1,811,042
| +34% | +$61.5M |
|
53
ExxonMobil
XOM
$635B
| $251M | 0.54% |
2,671,796
-247,754
| -8% | -$24.7M |
|
54
Intel
INTC
$435B
| $251M | 0.54% |
7,204,247
-582,218
| -7% | -$19.7M |
|
55
Occidental Petroleum
OXY
$53.9B
| $247M | 0.53% |
2,685,985
-269,579
| -9% | -$25.9M |
|
|
56
Viatris
VTRS
$20.7B
| $243M | 0.52% |
5,337,001
+4,270,204
| +400% | +$208M |
|
57
Comcast
CMCSA
$85.9B
| $239M | 0.51% |
8,880,214
-1,057,644
| -11% | -$29M |
|
58
Devon Energy
DVN
$49.3B
| $224M | 0.48% |
3,282,811
-373,896
| -10% | -$27.8M |
|
|
SCHW
59
Charles Schwab
SCHW
$184B
| $220M | 0.47% |
7,482,370
-93,625
| -1% | -$2.65M |
|
60
Union Pacific
UNP
$177B
| $218M | 0.47% |
2,009,689
-301,730
| -13% | -$31.2M |
|
61
IQVIA
IQV
$39.7B
| $215M | 0.46% |
3,854,835
-406,761
| -10% | -$22.7M |
|
|
CMCSK
62
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $212M | 0.46% |
3,965,894
-709,805
| -15% | -$38M |
|
63
Transocean
RIG
$5.57B
| $206M | 0.44% |
6,434,078
-195,188
| -3% | -$7.64M |
|
|
MJN
64
DELISTED
Mead Johnson Nutrition Company
MJN
| $201M | 0.43% |
2,087,642
-235,208
| -10% | -$22.3M |
|
65
Merck
MRK
$325B
| $201M | 0.43% |
3,550,980
-390,147
| -10% | -$21.9M |
|
66
IBM
IBM
$214B
| $199M | 0.43% |
1,099,220
-113,580
| -9% | -$20.7M |
|
67
Macy's
M
$6.61B
| $199M | 0.43% |
3,428,190
-498,164
| -13% | -$29.5M |
|
68
HDFC Bank
HDB
$122B
| $196M | 0.42% |
16,857,696
-791,656
| -4% | -$9.6M |
|
|
APC
69
DELISTED
Anadarko Petroleum
APC
| $194M | 0.42% |
1,910,886
-202,338
| -10% | -$21.8M |
|
70
Novartis
NVS
$304B
| $193M | 0.42% |
2,291,475
-68,885
| -3% | -$5.57M |
|
|
71
Mastercard
MA
$496B
| $193M | 0.41% |
+2,605,801
| New | +$198M |
|
|
DD
72
DELISTED
Du Pont De Nemours E I
DD
| $187M | 0.4% |
2,738,161
-303,324
| -10% | -$19.1M |
|
73
Ryanair
RYAAY
$30.9B
| $182M | 0.39% |
7,880,013
+558,736
| +8% | +$12.5M |
|
74
Costco
COST
$431B
| $181M | 0.39% |
1,447,375
+490,364
| +51% | +$59.3M |
|
75
CoreCivic
CXW
$3.05B
| $181M | 0.39% |
5,256,197
-113,938
| -2% | -$3.92M |
|
Similar funds
QCM
Lazard Asset Management's Q3 2014 Portfolio in Review
As of Q3 2014, Lazard Asset Management held 1,157 positions worth $46.6B, down 2.6% from $47.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Lazard Asset Management withdrew a net $2.28B in Q3 2014, closing 125 positions and reducing 323 holdings. Its most notable exit was TYCO INTL PLC COM SHS (IRL), an estimated $247M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Communication Services and Technology.
Against the trend, Lazard Asset Management opened a new position in Mastercard worth $193M.
- Lazard Asset Management's largest Q3 2014 buy was Mastercard: 2,605,801 shares worth $193M.
- Lazard Asset Management added most to Viatris in Q3 2014, an estimated $208M increase.
- Lazard Asset Management's biggest Q3 2014 reduction was Pfizer, cutting an estimated $179M.
- Lazard Asset Management fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2014, selling an estimated $247M.
- Lazard Asset Management's ten largest holdings make up 20% of its $46.6B portfolio in Q3 2014.
- Lazard Asset Management opened 166 new positions and closed 125 in Q3 2014.
- Lazard Asset Management's portfolio value fell 2.6% quarter-over-quarter to $46.6B.
Based on Lazard Asset Management's 13F filing for Q3 2014, filed 7 Nov 2014.